PortfoliosLab logoPortfoliosLab logo
SPIR vs. HALO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SPIR vs. HALO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Spire Global, Inc. (SPIR) and Halozyme Therapeutics, Inc. (HALO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SPIR achieves a 130.27% return, which is significantly higher than HALO's 2.51% return.


SPIR

1D
-8.96%
1M
-18.38%
YTD
130.27%
6M
90.62%
1Y
73.74%
3Y*
67.27%
5Y*
-26.35%
10Y*

HALO

1D
0.64%
1M
0.98%
YTD
2.51%
6M
1.22%
1Y
30.64%
3Y*
26.43%
5Y*
9.85%
10Y*
23.38%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SPIR vs. HALO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
SPIR
Spire Global, Inc.
130.27%-46.70%79.92%1.82%-71.60%-66.23%5.37%
HALO
Halozyme Therapeutics, Inc.
2.51%40.77%29.36%-35.04%41.51%-5.85%50.39%

Correlation

The correlation between SPIR and HALO is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Nov 3, 2020

0.14

The correlation between SPIR and HALO shifts across timeframes, from 0.01 (1 year) to 0.14 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

SPIR:

$574.57B

HALO:

$8.48B

EPS

SPIR:

-$3.07

HALO:

$2.87

PS Ratio

SPIR:

18.00

HALO:

5.57

PB Ratio

SPIR:

6.30

HALO:

38.60

Total Revenue (TTM)

SPIR:

$15.88B

HALO:

$1.51B

Gross Profit (TTM)

SPIR:

$6.33B

HALO:

$1.23B

EBITDA (TTM)

SPIR:

-$24.64B

HALO:

$980.05M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SPIR vs. HALO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SPIR
SPIR Risk / Return Rank: 6868
Overall Rank
SPIR Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
SPIR Sortino Ratio Rank: 6969
Sortino Ratio Rank
SPIR Omega Ratio Rank: 6868
Omega Ratio Rank
SPIR Calmar Ratio Rank: 6969
Calmar Ratio Rank
SPIR Martin Ratio Rank: 6767
Martin Ratio Rank

HALO
HALO Risk / Return Rank: 6767
Overall Rank
HALO Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
HALO Sortino Ratio Rank: 6767
Sortino Ratio Rank
HALO Omega Ratio Rank: 6565
Omega Ratio Rank
HALO Calmar Ratio Rank: 6767
Calmar Ratio Rank
HALO Martin Ratio Rank: 6464
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SPIR vs. HALO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Spire Global, Inc. (SPIR) and Halozyme Therapeutics, Inc. (HALO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SPIRHALODifference
Sharpe ratioReturn per unit of total volatility

-0.30

Sortino ratioReturn per unit of downside risk

+0.13

Omega ratioGain probability vs. loss probability

1.20

1.19

+0.02

Calmar ratioReturn relative to maximum drawdown

1.48

1.28

+0.21

Martin ratioReturn relative to average drawdown

2.90

2.38

+0.52

SPIR vs. HALO - Sharpe Ratio Comparison

The current SPIR Sharpe Ratio is 0.72, which is comparable to the HALO Sharpe Ratio of 1.01. The chart below compares the historical Sharpe Ratios of SPIR and HALO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SPIR vs. HALO - Drawdown Comparison

The maximum SPIR drawdown since its inception was -97.74%, which is greater than HALO's maximum drawdown of -74.26%. Use the drawdown chart below to compare losses from any high point for SPIR and HALO.


Loading charts...

Drawdown Indicators


SPIRHALODifference

Max Drawdown

Largest peak-to-trough decline

-97.74%

-74.26%

-23.48%

Max Drawdown (1Y)

Largest decline over 1 year

-50.04%

-24.13%

-25.91%

Max Drawdown (3Y)

Largest decline over 3 years

-66.22%

-33.92%

-32.30%

Max Drawdown (5Y)

Largest decline over 5 years

-97.74%

-49.06%

-48.68%

Max Drawdown (10Y)

Largest decline over 10 years

-49.06%

Current Drawdown

Current decline from peak

-88.30%

-15.07%

-73.23%

Average Drawdown

Average peak-to-trough decline

-77.97%

-31.86%

-46.11%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.51%

12.88%

+12.63%

Volatility

SPIR vs. HALO - Volatility Comparison

Spire Global, Inc. (SPIR) has a higher volatility of 39.83% compared to Halozyme Therapeutics, Inc. (HALO) at 8.94%. This indicates that SPIR's price experiences larger fluctuations and is considered to be riskier than HALO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SPIRHALODifference

Volatility (1M)

Calculated over the trailing 1-month period

39.83%

8.94%

+30.89%

Volatility (6M)

Calculated over the trailing 6-month period

80.75%

24.09%

+56.66%

Volatility (1Y)

Calculated over the trailing 1-year period

103.70%

30.40%

+73.30%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

98.51%

39.43%

+59.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

92.96%

42.82%

+50.14%

Dividends

SPIR vs. HALO - Dividend Comparison

Neither SPIR nor HALO has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

SPIR vs. HALO - Financials Comparison

This section allows you to compare key financial metrics between Spire Global, Inc. and Halozyme Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
15.83B
376.71M
(SPIR) Total Revenue
(HALO) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SPIR and HALO have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SPIR has higher volatility (39.83%) compared to HALO (8.94%). In terms of maximum drawdown, SPIR dropped -97.74% vs HALO's -74.26%.

HALO currently has the higher Sharpe Ratio (1.01 vs 0.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SPIR and HALO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer